Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Epiduo Samples on Adherence in Acne
NCT01504204Phase 4Completed
- Sponsor
- Wake Forest University
- Start
- Dec 2011
- Primary completion
- Nov 2012
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adapalene + benzoyl peroxide in acne vulgaris (2 arms), sponsored by Wake Forest University. Primary endpoint: Adherence to Study Medication at 6 weeks. Started Dec 2011; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01504204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504204.